Olin Announces Second Quarter 2023 Results

Olin defines segment earnings as income (loss) before interest expense, interest income, other operating income (expense), non-operating pension income, other income, and income taxes.

CHLOR ALKALI PRODUCTS AND VINYLS

In first quarter 2023, the Blue Water Alliance joint venture began operations and are consolidated in our Chlor Alkali Products and Vinyls segment. Chlor Alkali Products and Vinyls sales for the second quarter 2023 were $1,002.3 million compared to $1,403.5 million in the second quarter 2022. The decrease in Chlor Alkali Products and Vinyls sales was primarily due to 24% lower volumes partially offset by higher pricing. Second quarter 2023 segment earnings were $180.1 million compared to $346.5 million in the second quarter 2022. The $166.4 million decrease in segment earnings was primarily due to lower volumes partially offset by higher pricing across all products except vinyls intermediates, which declined. The Chlor Alkali Products and Vinyls second quarter 2023 segment results were also negatively impacted by $78.9 million for the maintenance turnaround and subsequent operating issues with the vinyl chloride monomer plant at the Freeport, Texas facility resulting in higher costs and reduced profit from lost sales. Chlor Alkali Products and Vinyls second quarter 2023 results included depreciation and amortization expense of $113.3 million compared to $120.4 million in the second quarter 2022.

EPOXY

Epoxy sales for the second quarter 2023 were $333.8 million compared to $772.7 million in the second quarter 2022. The decrease in Epoxy sales was primarily due to 24% lower resin and systems volumes and $206.9 million of lower cumene and bisphenol A sales. As part of the Epoxy business restructuring actions to right-size our global asset footprint to the most cost-effective asset base to support our strategic operating model, the Epoxy business ceased operations at our cumene facility in Terneuzen, Netherlands in first quarter 2023 and one of our bisphenol A production lines at our Stade, Germany facility in fourth quarter 2022. Second quarter 2023 segment loss was $0.5 million compared to segment earnings of $139.9 million in the second quarter 2022. The $140.4 million decrease in Epoxy segment earnings was primarily due to lower volumes and lower pricing, partially offset by lower raw material and operating costs, mainly decreased natural gas and electrical power costs. Epoxy second quarter 2023 results included depreciation and amortization expense of $15.2 million compared to $20.4 million in the second quarter 2022.

WINCHESTER

Winchester sales for the second quarter 2023 were $366.6 million compared to $439.9 million in the second quarter 2022. The decrease in Winchester sales was primarily due to lower commercial ammunition shipments, partially offset by higher domestic and international military sales. Second quarter 2023 segment earnings were $64.7 million compared to $119.3 million in the second quarter 2022. The $54.6 million decrease in segment earnings was primarily due to lower commercial ammunition shipments and pricing, and higher commodity and other materials costs, partially offset by higher military sales. Winchester second quarter 2023 included depreciation and amortization expense of $6.3 million compared to $5.9 million in the second quarter 2022.

CORPORATE AND OTHER COSTS

Second quarter 2023 charges to income for environmental investigatory and remedial activities were $13.0 million compared to $5.0 million in the second quarter 2022. The second quarter 2023 increase in charges relate primarily to future remedial activities associated with past manufacturing operations.

Other corporate and unallocated costs in second quarter of 2023 decreased $12.6 million compared to second quarter 2022 primarily due to lower incentive costs and lower legal-related costs.

LIQUIDITY AND SHARE REPURCHASES

The cash balance on June 30, 2023, was $161.1 million and Olin ended second quarter 2023 with net debt of approximately $2.6 billion and a net debt to adjusted EBITDA ratio of 1.4 times. During second quarter 2023, net debt decreased by $33.0 million. On June 30, 2023, Olin had approximately $1.3 billion of available liquidity.

During second quarter 2023, approximately 3.5 million shares of common stock were repurchased at a cost of $186.9 million. During first half 2023, approximately 7.1 million shares of common stock were repurchased at a cost of $393.0 million. On June 30, 2023, Olin had approximately $1.3 billion available under its current share repurchase authorization.

CONFERENCE CALL INFORMATION

Olin senior management will host a conference call to discuss second quarter 2023 financial results at 9:00 a.m. Eastern time on Friday, July 28, 2023. Remarks will be followed by a question-and-answer session. Associated slides, which will be available the evening before the call, and the conference call webcast will be accessible via Olin's website, www.olin.com, under the second quarter conference call icon. An archived replay of the webcast will also be available in the Investor Relations section of Olin's website beginning at 12:00 p.m. Eastern time. A final transcript of the call will be posted the next business day.

COMPANY DESCRIPTION

Olin Corporation is a leading vertically-integrated global manufacturer and distributor of chemical products and a leading U.S. manufacturer of ammunition. The chemical products produced include chlorine and caustic soda, vinyls, epoxies, chlorinated organics, bleach, hydrogen, and hydrochloric acid. Winchester's principal manufacturing facilities produce and distribute sporting ammunition, law enforcement ammunition, reloading components, small caliber military ammunition and components, and industrial cartridges.

Visit www.olin.com for more information on Olin.

FORWARD-LOOKING STATEMENTS

This communication includes forward-looking statements. These statements relate to analyses and other information that are based on management's beliefs, certain assumptions made by management, forecasts of future results, and current expectations, estimates and projections about the markets and economy in which we and our various segments operate. The statements contained in this communication that are not statements of historical fact may include forward-looking statements that involve a number of risks and uncertainties.

We have used the words "anticipate," "intend," "may," "expect," "believe," "should," "plan," "outlook," "project," "estimate," "forecast," "optimistic," "target," and variations of such words and similar expressions in this communication to identify such forward-looking statements. These forward-looking statements include, but are not limited to, statements regarding the Company's intent to repurchase, from time to time, the Company's common stock. These statements are not guarantees of future performance and involve certain risks, uncertainties, and assumptions, which are difficult to predict and many of which are beyond our control. Therefore, actual outcomes and results may differ materially from those matters expressed or implied in such forward-looking statements. We undertake no obligation to update publicly any forward-looking statements, whether as a result of future events, new information or otherwise. The payment of cash dividends is subject to the discretion of our board of directors and will be determined in light of then-current conditions, including our earnings, our operations, our financial conditions, our capital requirements and other factors deemed relevant by our board of directors. In the future, our board of directors may change our dividend policy, including the frequency or amount of any dividend, in light of then-existing conditions.

The risks, uncertainties and assumptions involved in our forward-looking statements, many of which are discussed in more detail in our filings with the SEC, including without limitation the "Risk Factors" section of our Annual Report on Form 10-K for the year ended December 31, 2022, and our Quarterly Reports on Form 10-Q and other reports furnished or filed with the SEC, include, but are not limited to, the following:

Business, Industry and Operational Risks

• sensitivity to economic, business and market conditions in the United States and overseas, including economic instability or a downturn in the sectors served by us;
• declines in average selling prices for our products and the supply/demand balance for our products, including the impact of excess industry capacity or an imbalance in demand for our chlor alkali products;
• unsuccessful execution of our strategic operating model, which prioritizes Electrochemical Unit (ECU) margins over sales volumes;
• failure to control costs and inflation impacts or failure to achieve targeted cost reductions;
• our reliance on a limited number of suppliers for specified feedstock and services and our reliance on third-party transportation;
• the occurrence of unexpected manufacturing interruptions and outages, including those occurring as a result of labor disruptions, production hazards and weather-related events;
• availability of and/or higher-than-expected costs of raw material, energy, transportation, and/or logistics;
• the failure or an interruption of our information technology systems;
• failure to identify, attract, develop, retain and motivate qualified employees throughout the organization;
• our inability to complete future acquisitions or joint venture transactions or successfully integrate them into our business;
• risks associated with our international sales and operations, including economic, political or regulatory changes;
• the negative impact from a public health crisis, such as a pandemic, epidemic or outbreak of infectious disease, including the COVID-19 pandemic and the global response to the pandemic, including without limitation adverse impacts in complying with governmental mandates;
• our indebtedness and debt service obligations;
• weak industry conditions affecting our ability to comply with the financial maintenance covenants in our senior credit facility;
• adverse conditions in the credit and capital markets, limiting or preventing our ability to borrow or raise capital;
• the effects of any declines in global equity markets on asset values and any declines in interest rates or other significant assumptions used to value the liabilities in, and funding of, our pension plans;
• our long-range plan assumptions not being realized causing a non-cash impairment charge of long-lived assets;

Legal, Environmental and Regulatory Risks

• changes in, or failure to comply with, legislation or government regulations or policies, including changes regarding our ability to manufacture or use certain products and changes within the international markets in which we operate;
• new regulations or public policy changes regarding the transportation of hazardous chemicals and the security of chemical manufacturing facilities;
• unexpected outcomes from legal or regulatory claims and proceedings;
• costs and other expenditures in excess of those projected for environmental investigation and remediation or other legal proceedings;
• various risks associated with our Lake City U.S. Army Ammunition Plant contract and performance under other governmental contracts; and
• failure to effectively manage environmental, social and governance (ESG) issues and related regulations, including climate change and sustainability.

All of our forward-looking statements should be considered in light of these factors. In addition, other risks and uncertainties not presently known to us or that we consider immaterial could affect the accuracy of our forward-looking statements.

2023-09

Olin Corporation
Consolidated Statements of Operations (a)
		Three Months			Six Months
		Ended June 30,			Ended June 30,
(In millions, except per share amounts)		2023	2022		2023	2022
Sales		$     1,702.7	$     2,616.1		$     3,547.0	$     5,077.5
Operating Expenses:
Cost of Goods Sold		1,392.6	1,951.4		2,834.3	3,758.9
Selling and Administration		101.2	99.0		213.0	203.3
Restructuring Charges (b)		19.2	3.6		80.1	6.7
Other Operating Income (c)		27.0	3.3		27.5	3.3
Operating Income		216.7	565.4		447.1	1,111.9
Interest Expense		45.3	34.5		87.7	67.4
Interest Income		1.1	0.3		2.2	0.7
Non-operating Pension Income		5.4	9.5		11.1	19.1
Income before Taxes		177.9	540.7		372.7	1,064.3
Income Tax Provision		33.2 Werbung Mehr Nachrichten zur Olin Aktie kostenlos abonnieren E-Mail-Adresse Bitte überprüfe deine die E-Mail-Adresse. Benachrichtigungen von ARIVA.DE (Mit der Bestellung akzeptierst du die Datenschutzhinweise) -1 Vielen Dank, dass du dich für unseren Newsletter angemeldet hast. Du erhältst in Kürze eine E-Mail mit einem Aktivierungslink. Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte. Andere Nutzer interessierten sich auch für folgende News 26.04.24 - ARIVA.DE Redaktion Börsen USA: S&P 500 profitiert gegenwärtig leicht (5.106 Pkt.) 26.04.24 - dpa-AFX Aktien New York: Alphabet und Microsoft sorgen für Nasdaq-Rally 26.04.24 - dpa-AFX ROUNDUP/Aktien Frankfurt: Klar erholter Dax schafft Wochenplus Biotech-Einhorn!    FDA Zulassung für das CBD-Wunder?! weiterlesen» Anzeige wo-site-teaser-box-16773_site-teaser-box_2024-04-27_09%253A00%253A00_2024-04-28_09%253A00%253A59